Silencing ephrin-B1 reduces tumor aggressiveness, a potential target for immunomodulatory or invasion-inhibiting therapies; Overexpression or activation of EphB1 could be explored to suppress tumor invasion; a potential therapeutic sensitizer. The gene discussed is EFNB1; the disease is neoplasm.